Broccoli Sprouts

PreclinicalSmall molecule

JJohns Hopkins University

Broccoli Sprouts is one of 76 small molecule programs targeting Lung Disease. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Lung DiseaseActive, not recruiting

Bladder CancerActive, not recruiting

Lung DiseasePreclinical

Active, not recruiting

Bladder CancerPreclinical

Active, not recruiting

Competition

Competitive Landscape

118 competitors in Bladder Cancer

#DrugCompanyPhaseTrials

Gemzar

Johnson & Johnson

Phase 3

52 2

Keytruda

Merck & Co.

Phase 3

27 3

Opdivo

Bristol-Myers Squibb

Phase 3

20 4

Platinol

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Phase 3

57 5

Imfinzi

AstraZeneca

Phase 3

16 6

Tecentriq

Roche

Phase 3

16 7

Trexall

Jazz Pharmaceuticals

Phase 3

12 8

Imjudo

AstraZeneca

Phase 3

8 9

Padcev

Pfizer

Phase 3

8 10

Gemzar

GGynecologic Oncology Group

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Inflammation2 trials

Effects of Whole Sprouts on Airway Allergic Inflammation

Completed·JJohns Hopkins University·N/A·NCT01522703·51 enrolled

Broccoli Sprout Extract Effects on Allergic Inflammation in the Nose

Completed·UUniversity of California, Los Angeles·N/A·NCT00882115·38 enrolled

Prevention1 trial

Prevention of Alcohol Intolerance

Completed·JJohns Hopkins University·Phase 2·NCT01845220·30 enrolled

Pilot Study1 trial

Broccoli Sprout Extracts in Healthy Volunteers: A Pilot Study of Nrf2 Pathway Modulation in Oral Mucosa

Completed·—·Phase 1·NCT02023931·10 enrolled

Breast1 trial

Study to Evaluate the Effect of Sulforaphane in Broccoli Sprout Extract on Breast Tissue

Completed·SSidney Kimmel Comprehensive Cancer Center at Johns Hopkins·Phase 2·NCT00982319·34 enrolled

Lung Disease1 trial

The Effects of Broccoli Sprout Extract on Obstructive Lung Disease

Completed·JJohns Hopkins University·N/A·NCT00994604·51 enrolled

2 more indications

Breast Cancer1 trial

Broccoli Sprout Extract in Treating Patients With Breast Cancer

Completed·RRoswell Park Cancer Institute·Phase 1·NCT01753908·30 enrolled

Bladder Cancer1 trial

Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery

Terminated·RRoswell Park Cancer Institute·N/A·NCT01108003·7 enrolled

Sources

References

[1]
ClinicalTrials.gov — 8 trial records for Broccoli Sprouts. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Broccoli Sprouts compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Broccoli Sprouts. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Johns Hopkins University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: JJohns Hopkins University

Broccoli Sprouts

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Inflammation2 trials

Prevention1 trial

Pilot Study1 trial

Breast1 trial

Lung Disease1 trial

Breast Cancer1 trial

Bladder Cancer1 trial

References

Drug Info

Quick Facts

Related News